Filing Flows › Inspire Medical Systems (INSP) › Recalls, complaints & regulation
Inspire Medical Systems (INSP): clinical trials
Inspire Medical Systems (INSP) beyond its filings: 5 active clinical trials.
Inspire Medical Systems' latest quarter
Inspire Medical Systems, Q3 2026: revenue $207M (-8% year over year), operating margin -13.9%, net loss $24.4M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Inspire Medical Systems have?
5 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.